Cholesterol-lowering effects and potential mechanisms of chitooligosaccharide capsules in hyperlipidemic rats

Background Chitooligosaccharide (COS) has shown potential antihyperlipidemic activity in a few studies as a functional food. Method We investigated the cholesterol-lowering effect and potential mechanisms of chitooligosaccharide capsules (COSTC) in male SD rats fed a high-fat diet. Results COSTC could ameliorate serum lipid levels. Simultaneously, the cholesterol-lowering effect is probably attributed to its role in two pathways: upregulating the gene expression and activity of cholesterol 7α-hydroxylase (CYP7A1), liver X receptor alpha (LXRA), and peroxisome proliferation activated receptor-α (PPARα), which facilitates the conversion of cholesterol into bile acid; downregulating the gene expression and activity of enzymes including 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) and sterol-responsive element binding protein-2 (SREBP2) and upregulating the low-density lipoprotein receptor (LDLR) to reduce the denovo synthesis of cholesterol. Conclusion Studies have suggested that COSTC has potential usefulness as a natural supplement or functional food for preventing and treating hyperlipidemia.

[1]  Mouming Zhao,et al.  Hypolipidemic effect of Youcha in hyperlipidemia rats induced by high-fat diet. , 2017, Food & function.

[2]  T. V. van Gulik,et al.  Atorvastatin does not protect against ischemia-reperfusion damage in cholestatic rat livers , 2017, BMC Surgery.

[3]  A. Espinosa,et al.  Effects of rosa mosqueta oil supplementation in lipogenic markers associated with prevention of liver steatosis. , 2017, Food & function.

[4]  V. Chatsudthipong,et al.  Chitosan oligosaccharide: Biological activities and potential therapeutic applications , 2017, Pharmacology & therapeutics.

[5]  Jiao Guo,et al.  Natural Products with Anti-obesity Effects and Different Mechanisms of Action. , 2016, Journal of agricultural and food chemistry.

[6]  S. Choi,et al.  Structure–activity studies of protease activating, lipase inhibiting, bile acid binding and cholesterol-lowering effects of pre-screened cumin seed bioactive peptides , 2016 .

[7]  Yubo Xiao,et al.  Rhizoma Coptidis alkaloids alleviate hyperlipidemia in B6 mice by modulating gut microbiota and bile acid pathways. , 2016, Biochimica et biophysica acta.

[8]  M. Serra-Prat,et al.  Oral Drugs Related with Muscle Wasting and Sarcopenia. A Review , 2016, Pharmacology.

[9]  Yubo Xiao,et al.  Hypolipidemic effects of Myrica rubra extracts and main compounds in C57BL/6j mice. , 2016, Food & function.

[10]  E. Tsochatzis,et al.  The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). , 2016, Metabolism: clinical and experimental.

[11]  A. Sanyal,et al.  Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease. , 2016, Metabolism: clinical and experimental.

[12]  D. Kleiner,et al.  Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. , 2016, Metabolism: clinical and experimental.

[13]  T. Xiao,et al.  Hypolipidemic effects of chitosan and its derivatives in hyperlipidemic rats induced by a high-fat diet , 2016, Food & nutrition research.

[14]  Jiao Guo,et al.  The effect of chitooligosaccharides on oleic acid-induced lipid accumulation in HepG2 cells , 2016, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.

[15]  Chi-Tang Ho,et al.  Ginger Essential Oil Ameliorates Hepatic Injury and Lipid Accumulation in High Fat Diet-Induced Nonalcoholic Fatty Liver Disease. , 2016, Journal of agricultural and food chemistry.

[16]  C. Che,et al.  Cholesterol-lowering effects and potential mechanisms of different polar extracts from Cyclocarya paliurus leave in hyperlipidemic mice. , 2015, Journal of ethnopharmacology.

[17]  H. Byun,et al.  Biological effects of chitosan and its derivatives , 2015 .

[18]  T. Xiao,et al.  Anti-Obese Effect of Glucosamine and Chitosan Oligosaccharide in High-Fat Diet-Induced Obese Rats , 2015, Marine drugs.

[19]  N. Al-Jbour,et al.  Influence of Molecular Weight and Degree of Deacetylation of Low Molecular Weight Chitosan on the Bioactivity of Oral Insulin Preparations , 2015, Marine drugs.

[20]  B. Moerschbacher,et al.  Enzymatic production of defined chitosan oligomers with a specific pattern of acetylation using a combination of chitin oligosaccharide deacetylases , 2015, Scientific Reports.

[21]  Philippe Lefebvre,et al.  Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease. , 2015, Journal of hepatology.

[22]  Sheng Hu,et al.  Preparation, characterization, and biochemical activities of N-(2-Carboxyethyl)chitosan from squid pens. , 2015, Journal of agricultural and food chemistry.

[23]  Yanshun Xu,et al.  Synthesis, characterization, and antimicrobial activity of kojic acid grafted chitosan oligosaccharide. , 2014, Journal of agricultural and food chemistry.

[24]  Takeshi Kimura,et al.  MicroRNA-33 regulates sterol regulatory element-binding protein 1 expression in mice , 2013, Nature Communications.

[25]  J. Chiang,et al.  Mechanism of tissue‐specific farnesoid X receptor in suppressing the expression of genes in bile‐acid synthesis in mice , 2012, Hepatology.

[26]  B. Han,et al.  Effects of molecular weights on the absorption, distribution and urinary excretion of intraperitoneally administrated carboxymethyl chitosan in rats , 2012, Journal of Materials Science: Materials in Medicine.

[27]  Guohua Song,et al.  Chitosan oligosaccharides promote reverse cholesterol transport and expression of scavenger receptor BI and CYP7A1 in mice , 2012, Experimental biology and medicine.

[28]  P. Park,et al.  Chitooligosaccharides decreases plasma lipid levels in healthy men , 2012, International journal of food sciences and nutrition.

[29]  A. Conesa,et al.  Differential expression in RNA-seq: a matter of depth. , 2011, Genome research.

[30]  H. Guillou,et al.  Liver X Receptor: an oxysterol sensor and a major player in the control of lipogenesis. , 2011, Chemistry and physics of lipids.

[31]  Daxin Wang,et al.  Chitosan oligosaccharide decreases very-low-density lipoprotein triglyceride and increases high-density lipoprotein cholesterol in high-fat-diet-fed rats , 2011, Experimental biology and medicine.

[32]  P. Dugo,et al.  Hypolipidemic effects of Citrus bergamia Risso et Poiteau juice in rats fed a hypercholesterolemic diet. , 2007, Journal of agricultural and food chemistry.

[33]  G. Bruscalupi,et al.  Independent behavior of rat liver LDL receptor and HMGCoA reductase under estrogen treatment. , 1996, Biochemical and biophysical research communications.

[34]  K. Ebihara,et al.  Interaction of bile acids, phospholipids, cholesterol and triglyceride with dietary fibers in the small intestine of rats. , 1989, The Journal of nutrition.

[35]  G. Schonfeld,et al.  Effects of dietary cholesterol and fatty acids on plasma lipoproteins. , 1982, The Journal of clinical investigation.

[36]  R. Ross,et al.  Hyperlipidemia and atherosclerosis. , 1976, Science.

[37]  Hailong Yu,et al.  Advances in characterisation and biological activities of chitosan and chitosan oligosaccharides. , 2016, Food chemistry.

[38]  H. Hwang,et al.  Chitosan oligosaccharides inhibit adipogenesis in 3T3-L1 adipocytes. , 2008, Journal of microbiology and biotechnology.